Living longer with HIV is one of medicine's greatest success stories, but longevity brings new challenges. By 2040, more than half of all people living with HIV are expected to be over the age of 50, and their health pathways during ageing are very heterogeneous. What does that mean for patients, clinicians, and health systems worldwide? Are our health systems ready for this shift in the HIV ageing demographics? In this episode, Amy Justice and Keri Althoff discuss The Lancet HIV Commission on Ageing and HIV: A global perspective, exploring why the future of HIV care must shift beyond viral suppression toward healthy ageing, integrated care, and what matters most to people living with HIV.
Click here to read the full commission and related material:
Podden och tillhörande omslagsbild på den här sidan tillhör
The Lancet Group. Innehållet i podden är skapat av The Lancet Group och inte av,
eller tillsammans med, Poddtoppen.